Severe liver disease in HIV patients - Evaluation of fibrosis: liver biopsy, fibrotest

被引:0
|
作者
Bailly, F [1 ]
机构
[1] Hop Hotel Dieu, Serv Hepatogastroenterol, F-69288 Lyon 02, France
来源
MEDECINE ET MALADIES INFECTIEUSES | 2004年 / 34卷
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:4 / 6
页数:3
相关论文
共 50 条
  • [21] ULTRASOUND EVALUATION, LIVER STIFFNESS MEASUREMENT AND BIOPSY FOR STAGING OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE: A COMPARATIVE STUDY
    Gaia, Silvia
    Carucci, Patrizia
    Spandre, Maurizio
    Cosso, Loretta
    Evangelista, Andrea
    Bugianesi, Elisabetta
    Cocuzza, Caterina
    Rizzetto, Mario
    Brunello, Franco
    HEPATOLOGY, 2011, 54 : 1232A - 1232A
  • [22] Severe liver disease in HIV patients -: Epidemiology and diagnosis
    Bourlière, M
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 : 1 - 3
  • [23] Diagnostic value of biochemical markers (Fibrotest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Ratziu, V
    Le Calvez, S
    Messous, D
    Charlotte, F
    Bonhay, L
    Munteanu, M
    Poynard, T
    JOURNAL OF HEPATOLOGY, 2004, 40 : 175 - 175
  • [24] Role of transjugular liver biopsy in the diagnostic and therapeutic management of patients with severe liver disease
    Esposito, A. A.
    Nicolini, A.
    Meregaglia, D.
    Sangiovanni, A.
    Biondetti, P.
    RADIOLOGIA MEDICA, 2008, 113 (07): : 1008 - 1017
  • [25] Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
    Soon, Gwyneth Shook Ting
    Wee, Aileen
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (05) : 104 - 111
  • [26] Fibrosis evaluation in chronic liver diseases:: Comparison of FibroScan® with liver biopsy, Fibrotest®, Forns score, APRI, hyaluronan, prothrombin time, and AST/ALT ratio
    Foucher, J
    Vergniol, J
    Castéra, L
    Le Bail, B
    Chanteloup, E
    Adhoute, X
    Darriet, M
    Bertet, J
    Couzigou, P
    de Ledinghen, V
    JOURNAL OF HEPATOLOGY, 2005, 42 : 78 - 79
  • [27] Diagnostic value of biochemical markers (FibroTest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
    Ratziu, V
    Le Calvez, S
    Imbert-Bismut, F
    Messous, D
    Charlotte, F
    Bonyhay, L
    Munteanu, M
    Poynard, T
    HEPATOLOGY, 2003, 38 (04) : 510A - 511A
  • [28] Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease
    Munteanu, M.
    Ratziu, V.
    Poynard, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (06) : 655 - 656
  • [29] Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
    Arai, Taeang
    Atsukawa, Masanori
    Tsubota, Akihito
    Kato, Keizo
    Abe, Hiroshi
    Ono, Hirotaka
    Kawano, Tadamichi
    Yoshida, Yuji
    Tanabe, Tomohide
    Okubo, Tomomi
    Hayama, Korenobu
    Nakagawa-Iwashita, Ai
    Itokawa, Norio
    Kondo, Chisa
    Kaneko, Keiko
    Emoto, Naoya
    Nagao, Mototsugu
    Inagaki, Kyoko
    Fukuda, Izumi
    Sugihara, Hitoshi
    Iwakiri, Katsuhiko
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
    Taeang Arai
    Masanori Atsukawa
    Akihito Tsubota
    Keizo Kato
    Hiroshi Abe
    Hirotaka Ono
    Tadamichi Kawano
    Yuji Yoshida
    Tomohide Tanabe
    Tomomi Okubo
    Korenobu Hayama
    Ai Nakagawa-Iwashita
    Norio Itokawa
    Chisa Kondo
    Keiko Kaneko
    Naoya Emoto
    Mototsugu Nagao
    Kyoko Inagaki
    Izumi Fukuda
    Hitoshi Sugihara
    Katsuhiko Iwakiri
    Scientific Reports, 11